- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2025 · Mar 30, 2025 | 196.67K sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 195.71K sh |
| Capex | Q1 2025 · Mar 30, 2025 | $15.3M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $19.71M |
| Operating Cash Flow | Q1 2025 · Mar 30, 2025 | $22.82M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $6.19M |
| Long Term Debt | Q1 2025 · Mar 30, 2025 | $675.42M |
| Long Term Debt | Q1 2025 · Dec 29, 2024 | $656.87M |
| Short Term Debt | Q1 2025 · Mar 30, 2025 | $29.66M |
| Short Term Debt | Q1 2025 · Dec 29, 2024 | $34.62M |
| Cash And Equivalents | Q1 2025 · Mar 30, 2025 | $150.08M |
| Cash And Equivalents | Q1 2025 · Dec 29, 2024 | $152.72M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $139.77M |
| Stockholders Equity | Q1 2025 · Mar 30, 2025 | −$340.06M |
| Stockholders Equity | Q1 2025 · Dec 29, 2024 | −$335.06M |
| Current Liabilities | Q1 2025 · Mar 30, 2025 | $485.47M |
| Current Liabilities | Q1 2025 · Dec 29, 2024 | $474.16M |
| Total Liabilities | Q1 2025 · Mar 30, 2025 | $2.82B |
| Total Liabilities | Q1 2025 · Dec 29, 2024 | $2.77B |
| Current Assets | Q1 2025 · Mar 30, 2025 | $403.13M |
| Current Assets | Q1 2025 · Dec 29, 2024 | $388.4M |
| Total Assets | Q1 2025 · Mar 30, 2025 | $2.48B |
| Total Assets | Q1 2025 · Dec 29, 2024 | $2.44B |
| Eps Diluted | Q1 2025 · Mar 30, 2025 | $0.04 |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.21 |
| Eps Basic | Q1 2025 · Mar 30, 2025 | $0.04 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.21 |
| Sga Expense | Q1 2025 · Mar 30, 2025 | $36.45M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $34.37M |
| Net Income | Q1 2025 · Mar 30, 2025 | $8.17M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$41.56M |
| Operating Income | Q1 2025 · Mar 30, 2025 | $34.89M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$24.33M |
| Revenue | Q1 2025 · Mar 30, 2025 | $282.86M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $261.94M |